medetomidine has been researched along with phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dickenson, AH; Kalso, EA; McQuay, HJ; Sullivan, AF | 1 |
Kalso, EA; Kontinen, VK | 1 |
2 other study(ies) available for medetomidine and phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide
Article | Year |
---|---|
FLFQPQRF-amide modulates alpha 2-adrenergic antinociception in the rat dorsal horn in vivo.
Topics: Adrenergic alpha-Agonists; Amino Acid Sequence; Analgesics; Animals; Electric Stimulation; Imidazoles; Medetomidine; Molecular Sequence Data; Nerve Fibers; Oligopeptides; Rats | 1991 |
Differential modulation of alpha 2-adrenergic and mu-opioid spinal antinociception by neuropeptide FF.
Topics: Adrenergic alpha-Agonists; Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Drug Synergism; Imidazoles; Male; Medetomidine; Morphine; Naltrexone; Narcotic Antagonists; Neuropeptides; Oligopeptides; Pain; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Receptors, Opioid, mu; Spinal Cord; Time Factors | 1995 |